Skip to main content
Caplight Logo









Reia

Reia

Private
Lyme, New HampshireHealthcare & Life Scienceshttps://reiahealth.com

Last Round

Grant

Jan 4, 2024

Total Funding Raised

$6.33M

Company Overview

Reia operates in Healthcare & Life Sciences and is based in Lyme, New Hampshire. Its latest recorded funding round was a Grant round in January 2024.

Reia is a therapeutic devices company that develops and markets a modern, collapsible pessary and applicator system for the non-surgical treatment of pelvic organ prolapse.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Reia Comparables

Compare Reia with similar companies based on industry and business-model similarity.

Reia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FemTherapeutics
86%
Personal Medical Corp
83%
Bioteque America Inc.
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Reia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 4, 2024
GrantMay 11, 2023
GrantJan 1, 2018
AcceleratorMay 23, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ariana Sopher

COO & Co-Founder

Founding Team

Meegan Daigler

CTO & Co-Founder

Founding Team

Kaitlin Maier

CEO & Co-Founder

Founding Team

For institutional investors. Book with your work email.

Reia Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 53% MoM, from 2.1K to 3.2K.

  • Mar 2, 2026

    Monthly visitors increased 39% MoM, reaching 3.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Reia Filings

Explore SEC and related filing metadata, where available.

Reia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Reia's valuation, stock price, and market status.

Is Reia a public or private company?

Reia is a private company.

What is the current stock price of Reia?

Reia is a private company, so its shares have no public market price. Caplight tracks Reia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Reia worth (valuation)?

Valuation information for Reia is not publicly available.

Can I buy Reia stock?

Reia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Reia's last funding round?

Reia's most recent funding round was Grant on January 4, 2024.

Who are the main investors in Reia?

Key investors in Reia include NIH RADx, MassChallenge Israel.

Will Reia IPO soon?

No public IPO plans have been announced for Reia.

How can I track Reia secondary market activity?

Caplight tracks bids, offers, and trades in Reia's shares on secondary markets.

Firmographic Details

HeadquartersLyme, New Hampshire
Employee Range3
Year Founded2017
Last FundingJan 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?